MENU
+Compare
BOUT
ETF ticker: NYSE ARCA
AS OF
Sep 25 closing price
Price
$38.38
Change
-$0.84 (-2.14%)
Net Assets
11.6M

BOUT stock forecast, quote, news & analysis

The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index")... Show more

Category: #Mid-Cap Growth
BOUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for BOUT with price predictions
Sep 25, 2025

BOUT sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for BOUT moved above the 200-day moving average on September 12, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BOUT advanced for three days, in of 367 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 300 cases where BOUT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for BOUT moved out of overbought territory on September 23, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 70 cases where BOUT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on September 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BOUT as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BOUT turned negative on September 25, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BOUT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BOUT broke above its upper Bollinger Band on September 18, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Alibaba Group Holding Limited (NYSE:BABA), AstraZeneca PLC (NASDAQ:AZN), Amgen (NASDAQ:AMGN), Southern Company (The) (NYSE:SO), Enterprise Products Partners LP (NYSE:EPD), Wheaton Precious Metals Corp (NYSE:WPM), Okta (NASDAQ:OKTA).

Industry description

The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index"). The fund normally invests at least 80% of its net assets (including borrowings for investment purposes) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock’s recent “resistance level,” with consideration for various market conditions. The fund is non-diversified.

Market Cap

The average market capitalization across the Innovator IBD® Breakout Opps ETF ETF is 180.5B. The market cap for tickers in the group ranges from 1.34B to 424.77B. BABA holds the highest valuation in this group at 424.77B. The lowest valued company is EH at 1.34B.

High and low price notable news

The average weekly price growth across all stocks in the Innovator IBD® Breakout Opps ETF ETF was 10%. For the same ETF, the average monthly price growth was 41%, and the average quarterly price growth was 179%. EH experienced the highest price growth at 9%, while OPCH experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the Innovator IBD® Breakout Opps ETF ETF was -4%. For the same stocks of the ETF, the average monthly volume growth was -4% and the average quarterly volume growth was -17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 69
P/E Growth Rating: 52
Price Growth Rating: 51
SMR Rating: 53
Profit Risk Rating: 44
Seasonality Score: -25 (-100 ... +100)
View a ticker or compare two or three
BOUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category MidCapGrowth

Profile
Fundamentals
Details
Category
Mid-Cap Growth
Address
Academy Funds Trust123 South Broad Street, Suite 1630Philadelphia
Phone
(215) 979-3750
Web
www.innovatorfunds.com